Effect of 18F-Fluoromisonidazole (18F-FMISO) PET Imaging on Evaluation of Hypoxia Before Lu-177 PSMA Treatment for Prostate Cancer
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
It is aimed to evaluate hypoxia before Lu-177 PSMA treatment in prostate cancer and to show its effect on treatment success with 18F-FMISO PET imaging, which allows in-vivo evaluation and quantification of tumor hypoxia, which is known to be one of the factors affecting radiotherapy resistance.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• over 18 years old
• Patients diagnosed with prostate cancer who were referred to our clinic for Lu-177 PSMA treatment and were found suitable for treatment
Locations
Other Locations
Turkey
Ankara University Medical School
RECRUITING
Ankara
Contact Information
Primary
Cigdem Soydal, Asc Prof
csoydal@yahoo.com
+903125956732
Backup
Ecenur Dursun, Res Ass
+903125956732
Time Frame
Start Date: 2024-02-01
Estimated Completion Date: 2026-02-01
Participants
Target number of participants: 30
Treatments
Experimental: Treatment arm
Patients who underwent FMISO PET imaging before Lu-177 PSMA radionuclide treatment for CRPC
Related Therapeutic Areas
Sponsors
Leads: Cigdem Soydal